Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read More
An interview with Keith Chaitoff, Divisional Vice President, US Marketing
Read MoreBioImagene announces a collaboration with the University of Pennsylvania School of Medicine and Rutgers, the state university of New Jersey to develop Companion Algorithms for next generation companion diagnostics for digital pathology.
Read MoreChina Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read MoreA team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Read More